DJIA 17,616.81 259.94 1.50%
NASDAQ 4,717.02 72.71 1.57%
S&P 500 2,042.91 30.02 1.49%
market minute promo

1.98 -0.05 (-2.46%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $1.98 -2.46%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.02
Previous Close $2.03
Daily Range $1.92 - $2.05
52-Week Range $1.86 - $5.30
Market Cap $185.5M
P/E Ratio 8.12
Dividend (Yield) $0.00 (0.0%)
Volume 116,896
Average Daily Volume 297,868
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

Avago Technologies' Memory, FBAR, and Connectivity Business Will Take It Higher

5 Stocks Ready to Break Out and Soar Higher

Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape

How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape

How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape

Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication fo

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication for Gaucher Disease

Sector Update: Health Care

Why Protalix BioTherapeutics (PLX) Stock Is Surging Today

3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

See More PLX News...

PLX's Top Competitors

PLX $1.98 (-2.46%)
Current stock: PLX
AMGN $167.06 (2.19%)
Current stock: AMGN
GILD $105.03 (2.57%)
Current stock: GILD
BIIB $345.50 (3.79%)
Current stock: BIIB